Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects

被引:494
作者
Gastaldelli, Amalia
Cusi, Kenneth
Pettiti, Maura
Hardies, Jean
Miyazaki, Yoshinori
Berria, Rachele
Buigoli, Emma
Sironi, Anna Maria
Cersosimo, Eugenio
Ferrannini, Ele
Defronzo, Ralph A.
机构
[1] CNR, Inst Clin Physiol, I-56100 Pisa, Italy
[2] Univ Texas, Hlth Sci Ctr, Dept Med, Div Diabet, San Antonio, TX USA
[3] Case Western Reserve Univ, Dept Obstet Gynecol, Cleveland, OH USA
[4] Univ Pisa, Dept Internal Med, Pisa, Italy
关键词
D O I
10.1053/j.gastro.2007.04.068
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background&Aims: Abdominal fat accumulation (Visceral/hepatic) has been associated with hepatic insulin resistance (IR) in obesity and type 2 diabetes (T2DM). We examined the relationship between visceral/hepatic fat accumulation and hepatic IR/accelerated gluconeogenesis (GNG). MethodS: In 14 normal glucose tolerant (NGT) (body mass index [BMI] = 25 +/- 1 kg/m(2)) and 43 T2DM (24 nonobese, BMI = 26 +/- 1; 19 obese, BMI = 32 1 kg/m(2)) subjects, we measured endogenous (hepatic) glucose production (3-H-3-glucose) and GNG ((H2O)-H-2) in the basal state and during 240 pmol/m(2)/min euglycemic-hyperinsulinemic clamp, and liver (1,17) subcutaneous (SAT)/visceral (VAT) fat content by magnetic resonance spectroscopy/magnetic resonance imaging. Results: LF was increased in lean T2DM compared with lean NGT (18% +/- 3% vs 9% +/- 2%, P < .03), but was similar in lean T2DM and obese T2DM (18% 3% vs 22% +/- 3%; P = NS). Both VAT and SAT increased progressively from lean NGT to lean T2DM to obese T2DM. T2DM had increased basal endogenous glucose production (EGP) (NGT, 15.1 +/- 0.5; lean T2DM, 16.3 +/- 0.4; obese T2DM, 17.2 +/- 0.6 mu mol/min/kg(ffm); P =.02) and basal GNG flux (NGT, 8.6 +/- 0.4; lean T2DM, 9.6 +/- 0.4; obese T2DM, 11.1 +/- 0.6 mu mol/min/kg(ffm); P= .02). Basal hepatic IR index (EGP X fasting plasma insulin) was increased in T2DM (NGT, 816 54; lean T2DM, 1252 +/- 164; obese T2DM, 1810 +/- 210; P =.007). In T2DM, after accounting for age, sex, and BMI, both LF and VAT, but not SAT, were correlated significantly (P < .05) with basal hepatic IR and residual EGP during insulin clamp. Basal percentage of GNG and GNG flux were correlated positively with VAT (P < .05), but not with LF. LF, but not VAT, was correlated with fasting insulin, insulin-stimulated glucose disposal, and impaired FFA suppression by insulin (all P < .05). Conclusions: Abdominal adiposity significantly affects both lipid (FFA) and glucose metabolism. Excess VAT primarily increases GNG flux. Both VAT and LF are associated with hepatic IR.
引用
收藏
页码:496 / 506
页数:11
相关论文
共 40 条
  • [1] Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients
    Bajaj, M
    Suraamornkul, S
    Hardies, LJ
    Pratipanawatr, T
    DeFronzo, RA
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 (06) : 783 - 789
  • [2] Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes
    Bajaj, M
    Suraamornkul, S
    Pratipanawatr, T
    Hardies, LJ
    Pratipanawatr, W
    Glass, L
    Cersosimo, E
    Miyazaki, Y
    DeFronzo, RA
    [J]. DIABETES, 2003, 52 (06) : 1364 - 1370
  • [3] Surgical removal of visceral fat reverses hepatic insulin resistance
    Barzilai, N
    She, L
    Liu, BQ
    Vuguin, P
    Cohen, P
    Wang, JL
    Rossetti, L
    [J]. DIABETES, 1999, 48 (01) : 94 - 98
  • [4] A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
    Belfort, Renata
    Harrison, Stephen A.
    Brown, Kenneth
    Darland, Celia
    Finch, Joan
    Hardies, Jean
    Balas, Bogdan
    Gastaldelli, Amalia
    Tio, Fermin
    Pulcini, Joseph
    Berria, Rachele
    Ma, Jennie Z.
    Dwivedi, Sunil
    Havranek, Russell
    Fincke, Chris
    DeFronzo, Ralph
    Bannayan, George A.
    Schenker, Steven
    Cusi, Kenneth
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (22) : 2297 - 2307
  • [5] METABOLIC ABNORMALITIES IN VISCERAL OBESITY
    BJORNTORP, P
    [J]. ANNALS OF MEDICINE, 1992, 24 (01) : 3 - 5
  • [6] TOTAL-BODY FAT-CONTENT AND FAT TOPOGRAPHY ARE ASSOCIATED DIFFERENTLY WITH INVIVO GLUCOSE-METABOLISM IN NONOBESE AND OBESE NONDIABETIC WOMEN
    BONORA, E
    DELPRATO, S
    BONADONNA, RC
    GULLI, G
    SOLINI, A
    SHANK, ML
    GHIATAS, AA
    LANCASTER, JL
    KILCOYNE, RF
    ALYASSIN, AM
    DEFRONZO, RA
    [J]. DIABETES, 1992, 41 (09) : 1151 - 1159
  • [7] Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
    Bugianesi, E
    Gastaldelli, A
    Vanni, E
    Gambino, R
    Cassader, M
    Baldi, S
    Ponti, V
    Pagano, G
    Ferrannini, E
    Rizzetto, M
    [J]. DIABETOLOGIA, 2005, 48 (04) : 634 - 642
  • [8] Insulin resistance: A metabolic pathway to chronic liver disease
    Bugianesi, E
    McCullough, AJ
    Marchesini, G
    [J]. HEPATOLOGY, 2005, 42 (05) : 987 - 1000
  • [9] Intramuscular and liver triglycerides are increased in the elderly
    Cree, MG
    Newcomer, BR
    Katsanos, CS
    Sheffield-Moore, M
    Chinkes, D
    Aarsland, A
    Urban, R
    Wolfe, RR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (08) : 3864 - 3871
  • [10] FASTING HYPERGLYCEMIA IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS - CONTRIBUTIONS OF EXCESSIVE HEPATIC GLUCOSE-PRODUCTION AND IMPAIRED TISSUE GLUCOSE-UPTAKE
    DEFRONZO, RA
    FERRANNINI, E
    SIMONSON, DC
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1989, 38 (04): : 387 - 395